阴道用黄体酮与足月时B族链球菌定植减少相关:一项回顾性队列研究
该回顾性观察性队列研究纳入2004年至2017年间为预防早产而使用孕激素且足月分娩的565例患者,比较阴道用黄体酮(173例)与肌内注射17α-羟孕酮己酸酯(392例)足月时B族链球菌(GBS)定植率。阴道用黄体酮组GBS定植率较低(19.7% vs 28.1%),多因素logistic回归校正混杂因素后,阴道用黄体酮与GBS定植减少相关(校正OR 0.61,95%CI 0.39-0.95)。作者结论为阴道用黄体酮与足月时直肠阴道GBS定植患病率降低相关。
要点
- 阴道用黄体酮组足月GBS定植率为19.7%,17α-羟孕酮己酸酯组为28.1%。
- 校正潜在混杂因素后,阴道用黄体酮与GBS定植减少相关(校正OR 0.61,95%CI 0.39-0.95)。
- 研究为回顾性观察性队列,作者结论为相关性而非因果结论。
核心结论
- 阴道用黄体酮与足月时直肠阴道B族链球菌定植患病率降低相关。
研究设计与样本
- 回顾性观察性队列研究,纳入2004年至2017年间为预防早产而使用孕激素且足月分娩的患者共565例,其中阴道用黄体酮173例、肌内注射17α-羟孕酮己酸酯392例。
- 排除妊娠<37周分娩、孕期更换孕激素类型、放置子宫托或行宫颈环扎者。
- 基线特征采用Mann-Whitney U检验或卡方检验比较,孕激素类型与GBS定植的关联采用双变量和多变量分析。
主要发现
- 阴道用黄体酮组GBS定植率为19.7%,17α-羟孕酮己酸酯组为28.1%,前者定植可能性较低。
- 多因素logistic回归校正潜在混杂因素后,阴道用黄体酮与GBS定植减少相关(校正OR 0.61,95%CI 0.39-0.95)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate whether women using intravaginal progesterone suppositories for preterm birth prevention during pregnancy will have lower rates of group B streptococcus (GBS) colonisation at term, compared with women receiving intramuscular 17-alpha-hydroxyprogesterone caproate. DESIGN: This was a retrospective observational cohort study of women who were prescribed a progestogen during their pregnancy for preterm birth prevention, and who delivered at term. SETTING: A tertiary referral hospital in central Ohio. POPULATION: Patients who were prescribed a progestogen during their pregnancy for preterm birth prevention between 2004 and 2017 were included in the study. Patients who delivered at <37 weeks of pregnancy, switched progestogen type during the pregnancy, or had a pessary or cerclage placed were excluded. METHODS: Baseline characteristics were compared using Mann-Whitney U-test or Chi-square test as appropriate. The association between type of progestogen and GBS colonisation was assessed using bivariate and multivariable analyses. MAIN OUTCOME MEASURES: The primary outcome was GBS colonisation. RESULTS: In all, 565 patients were included in the study, of whom 173 received intravaginal progesterone, and 392 17-alpha-hydroxyprogesterone caproate. Patients receiving intravaginal progesterone were less likely to be colonised with GBS (19.7 versus 28.1%). After adjustments for potential confounders were made in a multivariable logistic regression analysis, receiving intravaginal progesterone suppositories (adjusted odds ratio [OR] 0.61, 95% CI 0.39-0.95) was associated with reduced GBS colonisation. CONCLUSIONS: Intravaginal progesterone is associated with a decreased prevalence of rectovaginal GBS colonisation at term. TWEETABLE ABSTRACT: Vaginal progesterone is associated with a lower incidence of rectovaginal GBS colonisation, compared with 17α-hydroxyprogesterone caproate.
引用
- Ma'ayeh M, Rood KM, Walker HC, et al. Vaginal progesterone is associated with decreased group B streptococcus colonisation at term: a retrospective cohort study. BJOG. 2019. PMID: 31094064. doi:10.1111/1471-0528.15801
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。